Phase I dose-finding and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors

被引：0
|
作者：
Enzinger, Peter C. [1 ]
Earle, Craig [1 ]
Zhu, Andrew [1 ]
Blaskowsky, Lawrence [1 ]
Kulke, Matthew [1 ]
Ryan, David [1 ]
Langford, Lauren [1 ]
Michelini, Ann [1 ]
Meyerhardt, Jeffrey [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Partners Canc Care, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [41] Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors
    Rachamalla, R
    Malamud, S
    Grossbard, ML
    Mathew, S
    Dietrich, M
    Kozuch, R
    ANTI-CANCER DRUGS, 2004, 15 (03) : 211 - 217
  • [42] Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumors
    Nakanishi, Y
    Takayama, K
    Wataya, H
    Izumi, M
    Minami, T
    Takano, K
    Inoue, K
    Osaki, S
    Kimotsuki, K
    Harada, T
    Hara, N
    CHEMOTHERAPY, 2002, 48 (04) : 205 - 210
  • [43] A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer
    Gomez-Martin, C.
    Salazar, R.
    Montagut, C.
    Gil-Martin, M.
    Nunez, J. A.
    Puig, M.
    Lin, X.
    Khosravan, R.
    Tursi, J. M.
    Lechuga, M. J.
    Bellmunt, J.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (02) : 390 - 398
  • [44] A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer
    C. Gómez-Martín
    R. Salazar
    C. Montagut
    M. Gil-Martín
    J. A. Núñez
    M. Puig
    X. Lin
    R. Khosravan
    J. M. Tursi
    M. J. Lechuga
    J. Bellmunt
    Investigational New Drugs, 2013, 31 : 390 - 398
  • [45] A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Goto, Yasushi
    Tanioka, Maki
    Shibata, Takashi
    Yamada, Kazuhiko
    Asahina, Hajime
    Kawata, Toshio
    Shi, Xiaojin
    Tamura, Tomohide
    CANCER SCIENCE, 2012, 103 (03) : 504 - 509
  • [46] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yosuke Tamura
    Kazunori Honda
    Yoshitaka Seki
    Yuko Tanabe
    Hitoshi Shimada
    Xiaojin Shi
    Tomohide Tamura
    Investigational New Drugs, 2013, 31 : 677 - 684
  • [47] Phase I Dose-Finding Study for Pazopanib (P) and Paclitaxel (T) in Combination in the First-line Setting in Patients (pts) With Advanced Solid Tumours
    Kendra, K.
    Plummer, R.
    Salgia, R.
    O'Brien, M. E. R.
    Paul, E. M.
    Suttle, A. B.
    Ottesen, L. H.
    Villalona-Calero, M. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S146 - S146
  • [48] Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors
    Johnston, Donna L.
    Zupanec, Susan
    Nicksy, Darcy
    Morgenstern, Daniel
    Narendran, Aru
    Deyell, Rebecca J.
    Samson, Yvan
    Wu, Bing
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
  • [49] A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Tang, P.
    Oza, A.
    Townsley, C.
    Siu, L.
    Pond, G.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J.
    Chen, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Pierre Fumoleau
    Jose Manuel Trigo
    Nicolas Isambert
    Dorothée Sémiond
    Sunil Gupta
    Mario Campone
    BMC Cancer, 13
12345